Pattern Group Inc.

The following accounted for more than 10% of the Company’s total net receivables at: June 30, December 31, 2023 2022 Pattern, Inc. 39.3 % 23.7 % iHerb, Inc. * 29.6 % * Represents less than 10% Sales - Major customers who accounted for more than 10% of the Company’s total net sales were as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Pattern Inc. 29.1 % 33.2 % 30.3 % 30.9 % Fair Value Measurements ASC 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The following accounted for more than 10% of the Company’s total net receivables at: March 31, December 31, 2023 2022 Pattern, Inc. 46.5 % 23.7 % Gewu Zhipin (Shanghai) Network Technology Co., Ltd 16.5 % * iHerb, Inc. * 29.6 % * Represents less than 10% Sales - Major customers who accounted for more than 10% of the Company’s total net sales were as follows: Three Months Ended March 31, 2023 2022 Pattern Inc. 31.5 % 29.6 % Emerson Ecologics, LLC * 10.8 % iHerb, Inc. * 10.5 % * Represents less than 10% 12 Thorne HealthTech, Inc.Notes to Condensed Consolidated Financial Statements(unaudited)Fair Value Measurements Accounting Standards Codification (ASC) 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Major customers who accounted for more than 10% of the Company’s total receivables were as follows: As of December 31, 2022 2021 iHerb, Inc. 29.6 % 41.3 % Pattern, Inc. 23.7 % * Emerson Ecologics, LLC * 33.3 % * Represents less than 10% Sales - Major customers who accounted for more than 10% of the Company’s total net sales were as follows: Years Ended December 31, 2022 2021 Pattern, Inc. 32.6 % 24.8 % F-10 Thorne HealthTech, Inc. Notes to Consolidated Financial Statements InventoriesRaw materials consist primarily of powders, soft gels, and packaging components such as bottles, lids, and labels.

Major customers who accounted for more than 10% of the Company’s total net receivables were as follows: September 30, December 31, 2022 2021 iHerb, Inc. 26.1 % 41.3 % Emerson Ecologics, LLC 15.8 % 33.3 % Pattern Inc. 12.6 % * * Represents less than 10% Sales - Major customers who accounted for more than 10% of the Company’s total net sales were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Pattern Inc. 33.6 % 25.4 % 33.9 % 27.3 % Emerson Ecologics, LLC * * * 10.7 % iHerb, Inc. * 17.0 % * 15.9 % * Represents less than 10% In-process Research and Development In-process research and development (IPR&D) was recorded at its fair value using a discounted cash flow model and was assigned to acquired research and development assets that were not fully developed as of the completion of the acquisition of Drawbridge Health, Inc. (the Drawbridge Transaction; see Note 4).